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The diabetic foot ulcer is a common complication that develops in
individuals with diabetes mellitus. It is estimated that up to 15% of individuals
with diabetes will experience having a diabetic foot ulcer some time in their
lifetime (1). Having a diabetic foot ulcer can ultimately lead to many changes in
an individual's lifestyle. Some minor changes may include wearing special shoes
designed for individuals suffering from foot ulcers or daily changing dressings on
the ulcer. A major change that can occur in the lifestyle of an individual with a_
foot ulcer is amputation which has a devastating toll on a person.
Foot ulcers are common in people with diabetes mellitus. Twenty percent
of hospital admissions for patients with diabetes are due to lower extremity
problems (2). Many lower extremity amputations are performed due to non-
healing foot ulcers. There are approximately 1,000,000 individuals in Un-ted
States with diabetes that are suffering from lower extremity ulcers (2). Each
year there are about 86,000 patients with diabetes that require lower extremity
amputations due to diabetic ulceration (3). The single most common precursor
for lower-extremity amputations is ulceration. It is estimated that 84% of lower
extremity amputations in individuals with diabetes are caused by ulceration (4).
The two most common causes of diabetic foot ulcers are neuropathy and
peripheral vascular disease (5). Individuals with poorly controlled diabetes
develop these diseases (6). Neuropathy is nerve damage, usually in the lower
extremities, that causes loss of feeling. With the loss of sensation in the feet, the
individual can inflict trauma to the feet without knowing. ew pressure points on
the feet can also develop from changes in the individual's walking style due to
muscle atrophy caused from neuropathy. Wounds and new pressure points can
then lead to ulceration and infection.
Per~pheral vascular disease due to diabetes causes decreased blood flow
to the lower extremities. Blood flow is essential to deliver oxygen and nutrients to
the peripheral tissues and to carry away waste products from the tissues. With
decreased blood flow, tissues are unable to receive adequate oxygen and
nutrients needed by the cells for proper wound healing. Gangrene, sometimes
caused by an anaerobic bacteria, can develop with the absence of oxygen
caused by peripheral vascular disease. The low concentrations of oxygen in the
tissues allow the bacteria to survive and grow (4). Poor wound healing and the
development of gangrene due to peripheral vascular disease can lead to stasis
ulcers and possibly amputation (4).
There are many approaches for treating diabetic foot ulcers to prevent
amputations. Using a multidisciplinary treatment approach increases the
probability of healing. In a randomized study there was a 44 -85% decrease in
ulcers and amputations in patients that took part ·n a multid·sciplinary diabetic
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foot care program (7). Some treatments and preventive measures that were
utilized included thorough foot risk assessments by a physician, cal us and nail
care, customized foot wear, wound care and debridement, and patient education
from a multidisciplinary team with good knowledge of the foot (7). A relatively
new treatment for the healing of diabetic foot ulcers is hyperbaric oxygen therapy
(HBD). Most of all, good blood glucose control is an effective preventive
measure for all diabetic complications (1).
Hyperbaric oxygen therapy can reduce the risk of amputation in people
with diabetic foot ulcers (2,8). In one study, subjects that received hyperbaric
oxygen for the treatment of a diabetic foot ulcer had a significantly lower
occurrence of amputation compared to subjects that did not receive hyperbaric
oxygen therapy (8).
Good glycemic control can decrease the risk of amputation in individuals
with diabetic foot ulcers. Poor glycemic control is a significant predictor of the
incidence of amputation (9). Studies have not been conducted to examine
glycemic control of subjects with diabetes receiving hyperbaric oxygen therapy
that resulted in successful wound healing or amputation.
The objective of this study is:
To determine if there is a significant difference in glucose concentrations of
diabetic subjects receiving hyperbaric oxygen therapy that had successful wound
healing and compared to those that had amputations.
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Therefore the hypothesis of this study is:
Subjects with diabetes receiving hyperbaric oxygen therapy for the treatment of
diabetic foot ulcers with successful wound healing will have better glucose
concentrations compared to those that had amputations.
This study compares glucose concentrations to the success of healing of
diabetic foot ulcers in subjects receiving hyperbaric oxygen therapy. The results
of this study will be beneficial in identifying a possible adjunctive multidisciplinary
approach for the treatment of diabetic foot ulcers and a preventative measure to




Diabetes mellitus is a common disease that has a major impact on an
individual's life. This disease is a precursor to many other diseases and
complications. One of the complications that can change the quality of life for an
individual with diabetes is a foot ulcer. Many interventions are utilized to prevent
and treat diabetic foot ulcers such as good glycemic control, wearing proper
footwear, debridement, vascular reconstruction, keeping weight off the foot, and
hyperbaric oxygen therapy. If the diabetic foot ulcer is not cared for properly, the
risk for an amputation increases (Table 1). Undergoing an amputation can be
~evastating for a person and drastically affects quality of life.
Using a multidisciplinary treatment approach increases the probability of
healing. Good glycemic control is one approach that has been shown to improve
the healing of ulcers and prevent further development of ulcers (6,9). Hyperbaric
oxygen therapy is a relatively new method of treatment in the healing of diabetic
foot ulcers and has been shown to increase the healing rate and decrease the
risk of major amputation (2,8). The combination of glycemic control, regular
wound care and hyperbaric oxygen therapy may be a good combination for the
treatment of foot ulcers and prevention of amputation. This chapter will review
5
diabetes, glycemic control, diabetic foot ulcers, treatments used for diabetic foot
ulcers, wound healing, and hyperbaric oxygen therapy.
Diabetes and Glycemic Control
Diabetes mellitus is a major chronic metabolic disorder that has been
diagnosed in approximately 5-6% of the population of the United States. This
accounts for about 17 million people, and over 5 mil ion of these people are
unaware that they have this disease (3). Each year about 800,000 people are
diagnosed with this life long condition (3). Minority groups including African-
Americans, Mexican Americans, and Native Americans are the most frequently
affected by diabetes (10). The National Center for Health Statistics estimated
that 64,751 deaths in 1999 were caused by diabetes in the United States. This is
a rate of 13.6 deaths per 100,000 deaths (11). This mortality estimate is thought
to be underestimated because this estimate only accounts for people with theit
primary diagnosis as diabetes. Taking into account that diabetes ·s a prec rsor
of many other long term life threatening diseases such as nephropathy,
neuropathy, retinopathy, cardiovascular disease, and peripheral vascular disease
the estimated number of deaths is 193,140 (3). Diabetes increases the risk of
heart disease and stoke in adu ts 2-4 times higher than adults without diabetes
(3).
The definition of diabetes mellitus is the absence of insulin, insufficient
amount of insulin, or insulin not properly used by target tissues (12). Diabetes
mellitus is divided into two etiopathogenetic categories which are type 1 and type
2 diabetes. This metabo ic disease is characterized by hyperglycemia and some
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of the symptoms that are indicators of hyperglycemia are polyu ia, polydispia,
blurred vision, and weight loss. Ketoacidosis that may occur in some individuals
with diabetes, is a dangerous, life threatening effect of hyperglycemia (13).
Type 1 diabetes can be immune-mediated or idiopathic. Immune-
mediated diabetes is developed from an autoimmune destruction and
malfunction of beta cells in the pancreas. The cause of the destruction of beta
cells may be related to genetic characteristics or to environme'ntal factors that
have not been clearly defined. The destruction of beta cells stops the production
of insulin and the pancreas ultimately is unable to regulate glucose levels in the
blood. The rate of destruction of beta cells in the pancreas is d-fferent in ea,ch
person. The rate of destruction is usually faster in infants and children and
slower in adults_ The first indication of type 1 diabetes in many children and
adolescents is ketoacidosis. Others may experience mild hyperglycemia and
then develop severe hyperglycemia or ketoacid'osis when infection or stress "s
present. For many adults, beta cell function may remain adequate to prevent
ketoacidosis from occurring for a long period. Eventually, individuals with type 1
diabetes become dependent on insulin replacement therapy for survival (13).
Type 1 diabetes can also be idiopathic. Individ·uals with th·s k" d of type 1
diabetes have no autoimmune destruction present but have ittle or no insulin
production and are likely to develop ketoacidosis. The level of insulin ava·'able
to the body changes and the requirement for insulin replacement therapy may
come and go. Only a minority of indiv·duals have this condit·on and most t at do
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are of African or Asian descent. Idiopathic diabetes is inherited and there is no
evidence of destruction of beta cells by an autoimmune react·on (13).
Type 2 diabetes occurs in individuals who develop insulin resistance and
may progress to insulin deficiency. Years may pass without diabetes being
diagnosed because hyperglycemia develops slowly in the beginning and the
signs of hyperglycemia may not be strong enough for the individual to not·ce.
Many individuals with type 2 diabetes do not require the use of insulin
replacement therapy to survive, but some may require insulin after several years
with diabetes. This type of diabetes is not caused by autoimmune destruction of
beta cells. The causes of type 2 diabetes have not been clear y defined but there
is genetic a link for this disease. Some of the characteristics of individuals with
type 2 diabetes include being overweight or obese with increased percentage of
body fat in the abdominal area and physical inactivity (13). Type 2 diabetes may
be also associated with hyperlipidemia and polycystic ovary syndrome.
Glycemic control is the primary treatment goal for individuals with
diabetes. Glycemic control <;an be defined as maintain·ng blood glucose levels
within an acceptable range. The normal range for fasting blood glucose levels is
<110mg/dL. Those with impaired glucose tolerance (pre-diabetes) have fasting
blood glucose levels of ~110 and <126mg/dL or a random concentration of ~140
and <200mg/dL and individ'uals with fasting blood glucose levels >126mg/dL
have diabetes (11). Self-monitoring of blood glucose is a method to monitor
glycemic control. A person with diabetes can work wi h a dietit·an and other
healthcare professionals to determine the best behaviors for achieving the idea
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glucose range. By self-monitor·ng their blood glucose and by trying various
combinations of diet, exercise and medication, the indiv·dual and healthcare
provider can determine the best combination for optimal blood glucose control.
The Diabetes Control and Complications Trial clearly demonstrated that
good glycemic control reduced the incidence and prevalence of retinopathy,
nephropathy, and neuropathy in people with type 1 diabetes (6). Retinopathy
was 60% less prevalent in subjects with intensive self-monitoring of blood
glucose and insuHn treatment compared to the control group. In the study,
subjects who took part in intensive insulin therapy had a reduction in progression
in renal disease as evidenced by a 39% redu,ction in incidence of
microalbuminuria and a 54% reduction in incidence of macroalbuminuria. This
study also reported that those who achieved near normal glycemic control had a
69% reduction in subclinical neuropathy and a 57% reduction in clinical
neuropathy compared to control subjects (6). Neuropathy is one of the lead·ng
causes of foot ulcers and sores (5).
Hemoglobin A1c (HbA1c) is an accurate method to assess glycemic
control because is reflects glycemia over the past 6 to 12 weeks. Hemoglobin
A1C can be quantified to measure the amount of hemoglobin that is glycosylated.
Individuals with good glycemic control have an HbA1c of <6%. The goal for
individuals with diabetes is to have HbA1c <7% and those that need intervent·on
have HbA1c >8% (11).
Individuals with elevated glycosylated hemoglobin concentrations have a
higher incidence of developing sores or ulcers compared to individuals with near
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normal glycosylated hemoglobin concentrations. Persons taking insu in a greater
risk of developing sores and ulcers compared to those who do not take insulin
(9). Some of the other independent risk factors for developing sores or ulcers
are long duration of diabetes, proteinuria, and low diastolic blood pressure. All of
these risk factors with the addition of being male are also predictors for
amputation (9).
Poorly controlled diabetes is a precursor of many long-term complications
and is the leading cause of blindness, end stage renal disease (ESRD) and
amputation (14). Retinopathy caused by diabetes is the leading cause for
blindness in people aged 20-74 years (10). In 1996,42°1'<, of new cases of ESRD
were in patients with diabetes (15). The U.S. National Hospital Discharge survey
showed that 51 % of nontraumatic lower limb amputations were performed on
individuals with diabetes from 1989-1991. Amputations were performed to
remove toes (40%), foot and ankle (15°k), and limbs below the knee (25°k) or
above the knee (200/0) (16).
Good glycemic control can reduce the risk of many life long diseases and
reduce the incidence of foot sores and ulcers (6). The risk of amputation would
decrease also. Reducing in the risk for these diseases could prolong and
provide a better quality of life. For individuals with diabetes, good glycemic
control should be the primary goal for the control of the disease and their health.
Despite the evidence that good glycemic control is beneficial for people with
diabetes, many with this disease have poor glucose control because they are
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limited in their access to consistent and continuous health care, insulin therapy
and other therapies available for the management of diabetes (17).
Diabetic Foot Ulcers
Diabetic foot ulcers are a problem of great concern that can change an
individual's quality of life and health. Foot ulcers are one of the most common
long-term complications of diabetes. It is estimated that 15% of all people with
diabetes will be affected with a foot ulcer in their lifetime and of this 150/0, males
aged 45-64 years old are at the highest risk for develop·ng a foot ulcer (16). In
this era, there have been many changes in treatment approaches to save the
diabetic foot from infection, gangrene and amputation. Currently there are no
widely accepted guidelines for preventing, assessing and treating the diabetic
foot ulcer. To date, treatment has been based on consensus and scientific
methodology to determine the best approach (18). With today's understanding of
the pathophysiology of the diabetic foot, treatment can be custom·zed to the
individual to meet their needs.
Diabetic foot ulcers are defined as local defects to the surface of skin
caused by the sloughing of necrotic inflammatory tissue (19). The most common
location of a foot ulcer is on the plantar region of the foot (20). Other common
areas that foot ulcers form are on the top of toe joints (Appe.ndix A). The severity
of the ulcer is based on the depth, presence of infection and peripheral vascular
disease. Diabetic foot ulcers range from superficial to deep ulcers to the tendon,
bone, or joint. Infections also vary in severity. In severe ulcers, ·nfect·on,
abscess, osteomylitis, ischemia and gangrene can develop (4).
11
The wound healing process includes four phases that overlap. They are
the hemostatic phase, the inflammatory phase, the proliferation, mat ration or
connective tissue phase and the remodeling or epithelial phase. The hemostatic
phase starts as soon as the wound occurs wherein platelets and leukocytes
initiate blood coagulation and the beginning of the inflammatory phase. During
the inflammatory phase, leukocytes ingest bacteria and debris in the wound and
macrophages begin the connective tissue phase by releasing growth factors to
stimulate the synthesis of capillaries to vascularize the tissue. The connective
tissue phase promotes closing the wound by fibroblasts producing collagen and
begins the epithelial phase by myofibrils facil"tating epidermal coverage. The
epithelial phase is the last phase in wound healing in which the epithelial cells
begin covering the wound. The wound is considered to be healed only when the
tissue strength is normal and is across the entire wound (21).
One system that is used to describe the severity of wounds is the red-
yellow-black system (22). It uses color to identify the stage the wou d is in
during the healing process. Red wounds indicate that it is in the inflammatory or
the proliferationl maturation phase of wound healing. Yellow wounds indicate
that the wound is not ready to eal due to infection or the wound contains
fibrinous slough. Black wounds are not in the healing phase due to necrotic
tissue (22).
Another system used to describe the severity of foot ulcers is the Wagner
scale (4). It is one of the most commonly cited diabetic wound classification
systems used. This system has six grades (0-5) and is based on the depth of the
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wound. A higher grade indicates the wound is deeper and more severe. Grade
orepresents skin that is intact, grade 1 indicates a superficial ulcer, grade 2 is a
deep ulcer to the tendon, bone or joint, grade 3 is a deep ulcer with abscess or
osteomyelitis, grade 4 is forefoot gangrene and grade 5 is whole foot gangrene
(4).
Peripheral neuropathy and per·pheral vascular disease are two diseases
that develop with poorly controlled diabetes and are the leading causes of foot
ulcers (5). These conditions cause changes to the lower extremities that
increase the risk of developing foot ulcers. The severity of the ulcer also depends
on the amount of blood that is available to the tissue. The presence of periphera
vascular disease can greatly impact the severity of the ulcer by depriving the
tissue of oxygen needed to heal the tissue and fight infection (4).
Peripheral neuropathy is nerve dysfunction that affects sensation of the
lower extremities, especially in the foot. This disease causes functional
disturbances and pathologic changes in the peripheral nervous system. The
nerves in the lower limbs are affected and often the autonomic nerves are also
affected. The pathology of this disease is segmental demyelination of the
peripheral nerves. Without a myelin sheath around the per·pheral nerves,
transmissions of impulses are slowed and damage is caused to the nerves (19).
This disease is associated with an 8 to 18 fold higher risk of ulceration and a 2 to
15 fold higher risk of amputation (1). The prevalence of this condition increases
with age, duration of diabetes, presence of microvascular complicat·ons, and
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poor glycemic control (23). It affects up to 50% of the people who have had
diabetes for more than fifteen years (24).
Peripheral neuropathy is the cause of several changes in the lower
extremities. One change is loss of sensation which leads to extensive damage to
the foot because the sensations that signal an individual to protect their feet
(such as pain, pressure, and temperature) are lost (1). Individua!ls with the loss
of sensation can cause trauma to the foot without knowing it. When trauma is
unattended, it ultimately leads to infection and ulceration"
Atrophy of the intrinsic muscles is another change that can occur with
peripheral neuropathy" This results 'i'n flexion deform"ty. Th"s condition causes
limitations to the full movement of the foot and leads to changes in an individual's
gait. Changes in gait increase pressure under the metatarsal heads and the
toes, increasing the risk for ulcer development in these areas (1).
Lastly, peripheral neuropathy can also decrease perspiration in the foot
leading to dry skin that causes cracks and fissures in the feet (5). All these
changes caused by peripheral neuropathy increase the risk of developing ulcers
and delay the healing of ulcers that already exist.
Peripheral vascular disease (PVD), on the other hand, is atherosclerosis
of the peripheral blood vessels. This disease is "dentified by intermittent
claudication and/or the absence of peripheral pulse or blood flow in the lower
limbs and feet (25). Individuals with diabetes are 2-3 times more likely to
develop this PVD than the general population (26) and the preva ence of this
disease increases with age and the duration of diabetes (25). Only 5-7% of
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ulcers are due to peripheral vascular disease and is not a leading cause of foot
ulcers (27).
Although peripheral vascular disease may not be the leading cause of the
development of foot ulcers, it has profound effects on the progression of healing.
Due to decreased blood perfusion in the lower limbs, the risk for infection, poor
healing of sores and ulcers, and gangrene increases. If the ulceration is unable
to heal, it can ultimately lead to amputation. Almost half of amputations are
attributed to peripheral vascular disease (28). When an individual must undergo
an amputation there is a 28-51% chance that within five years the individual will
require a second amputation and unfortunately, three years after an amputation
the survival rate is less than 50% (25).
Peripheral vascular disease decreases oxygen supply to the tissues in the
lower extremities. Peripheral vascular disease affects the femoral and iliac
arteries in all individuals but in diabetics it is more likely to also have involvement
with the peroneal and tibial vessels (1). Vessel occlusion that occurs with th·s
disease inhibits adequate blood circulation to the lower legs and feet. With
decreased arterial circulation in the lower extremities, there is inadequate
cutaneous perfusion of oxygen (16). Cutaneous circulation indicates the amount
of oxygen diffusion across the skin which is measured by using transcutaneous
oxygen tension (TcP02) values. Values of TcP02 can predict the potential for
the healing of lower extremity wounds. A TcP02 value of < 20 mmHg is
associated with poor healing while 20-40 mmHg is associated with ·ntermed·ate
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healing and values >40 mmHg are associated with a h·gh likelihood of healing
(29).
The amount of oxygen saturation of the tissues is one determining factor
in healing. Fibroblasts synthesize collagen only when there is adequate oxygen
in the tissues. Peripheral vascular disease does not allow for adequate oxygen
saturation of the tissues. Hypoxia caused by periphera vascu.lar disease
prevents fibroblasts from synthesizing collagen to initiate wound healing (30).
Other factors along with adequate oxygen saturation of tissue that should
be considered in the wound healing process are nutritional status and delivery of
nutrients to the tissues. The wound healing process is dependent on the
presence of oxygen and nutrients in each phase. During all phases of wound
healing, blood flow and good nutritional status are essential. Good blood f ow
enables the delivery of oxygen and all the needed nutrients and factors that
promote the healing process. The delivery of glucose to the wound serves as the
primary source of energy and promotes phagocytic activity of the lymphocytes
(21). The presence of hyperglycemia however is a risk factor for poorer wound
healing due to the loss of other nutrients from glycosuria (31). The delivery of
protein to the wound is essential to assist in cellular multiplication, fibroblastic
proliferation and collagen synthesis. Collagen synthesis requires adequate
amounts of vitamin A, C, B-complex vitamins and copper (21).
Amino acids are the building blocks for collagen synthesis. Vitamins A, B
(thiamin), C, E, and K; the minerals ca c·um, copper, and zinc are all essential for
wound healing- to occur. Vitamin A provides a defense system against infections
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and complications that may occur. Vitamin K pro ects against infection by
promoting blood clotting and preventing prolonged bleeding. Vitamin C is an
essential cofactor for the synthesis of co lagen and thiamin is used to strengthen
collagen. With the absence of vitamin E the synthes·s of collagen maybe
impaired and slow down the process of wound healing. Calcium is a cofactor
during collagen remodeling and copper is needed by collagen to enhance scar
strength. Zinc is essential for the synthesis of nucleic acid that is necessary for
many enzymatic reactions to occur during wound healing (21).
Adequate intake of food or other nutritional interventions (Le. tube feeding,
supplements) are essential for proper wound healing. The wound needs good
nutrition, such as adequate calor1es, protein, vitamin and minerals, and fluids, to
make wound healing possible. Any element that causes malnutrition will retard
the wound healing process (21). Many times, the stage or severity of the wound
is related to nutritional deficits, especially inadequate protein intake reflected by
low serum albumin levels (32). A depressed level of serum albumin increases
the risk of poor wound healing by threefold with each gram decrease in serum
albumin (21). For individuals with wounds, the recommended amount of protein
needed for the wound to heal is 1.2-1.5g/kg (32).
Other than protein, the vitamins and minerals discussed previously are
needed to assist in the wound hearng process. For individ als that do not
receive adequate vitamins and minerals in their diet should take a multivitamin
daily to aid in the wound healing process (32). Individuals that most likely need
supplementation are those that have lost <10% of lean body mass. The weight
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loss is an indicator that the indiv·dual most likely has not received proper
nutrition.
Nutrition plays an important role in wound healing. In a study, individuals
with chronic ulcers had significantly lower levels of serum Vitamin A, Vitamin E,
zinc, and carotenes compared to healthy individuals i'n the Boston area. This
study concluded that nutritional defic'iencies of these nutrients may have a
negative effect on wound healing (33).
Steps that the indivodual can take to assist in the hea,ling of a diabetic foot
ulcer are keeping weight and stress off the foot, wearing special foot wear,
debriding the wound, maintaining a moist environment with dressings, managing
infection, undergoing vascular surgery, and controlling diabetes (34).
Keeping stress off the foot, also called off-loading, can be done in several
ways. One way to keep stress of the foot is by a total contact cast (TCC). The
TCC is applied to the foot to keep pressure off wounds on the planter part of the
foot. TCC is used only in individuals who do no have any infection or ischemic
wounds. Other treatments for off-loading are bed rest, surgical shoes, half
shoes, sandals, and felted foam dressings. Bed rest is the only intervention that
does not require the use of crutches. The top priority for the individual is to keep
the foot off the ground as much as possible. Continuance of these interventions
for approxim"ately two weeks after the ulcer heals ·s recommended to g·ve the
wound time to mature and prevent the recurrence of the ulcer (18).
Footwear that is customized to fit the individual properly can reduce
pressure, prevent trauma, and reduce the formation of cal uses and ulcers in
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people with diabetes (1). Special footwear can also protect an ex·sting ulcer from
further damage. Some principles for choosing the right footwear are summarized
by Tovey (35). One principle is to choose a shoe that is the right size, reduces
pressure to the plantar area of the foot, reduces shock, and forms around any
deformities of the foot. The shoe should be longer than the top of the longest toe
by at least 3/8 inch to provide enough room. The heel of the shoe should fit
comfortably without any rubbing on the heel. For individuals with edema or
deformities of the foot, shoes with laces are best to allow for adjustments to form
around the foot properly. Following these principles, prevents development of
ulcers in high-risk people.
Debridement of dead tissue from the wound area assists in wound
healing. A healthcare provider removes the tissue with a scalpel and forceps. If
the wound is not infected, debridement can be done on an outpatient basis. If
the wound is infected, most debridements will occur in-patient. This process
removes all necrotic tissue and drains the wound to prevent any pooling of pus
that might occur. Sharp debridement is a safer method of debridement
compared to whirlpool or other hydrotherapies. It reduces the risk of developing
infections or burns that hydrotherapies may cause (18).
Keeping the wound in a moist environment is important in the healing
process. Dressings are used to maintain and provide the wound with moisture.
Dressings also are used to prevent infection and prevent further trauma to the
wound. The type of dressing used is important to ensure -t will provide the
wound with the appropriate environment for healing to occur. Guidelines for
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choosing dressings are the wound type, presence of exudate, condition of
surrounding sk·n,likelihood of reinjury, and cost. Dressings can be a low cost
treatment because the individual or a caregiver can change the dressing at
home. Dressings should be used with off-loading and debr'dement to produce
the best results for wound healing (18).
Management of infection can assist in wound healing and help prevent the
possibility of amputation. Identifying an infected wound is based on clinical
evidence rather than microbiological evidence. All wounds have potentially
pathogenic organisms present but the wound may not be infected. Clinical
criteria such as the presence of pus or two or more signs of inflammation are
signs that infection is present. When infection is identified the use of
antimicrobial therapy is put in place (18).
Vascular reconstruction is used in patients with poor circulation in the
foot. No infection can be present to perform this surgery. This s rgery is able to
reconstruct the vessels in the foot to provide better circulation which will then
restore arterial flow and pulse to the foot (18). Vascular reconstruction has been
shown to heal wounds quickly and reduce amputations (36).
Treating the diabetic foot wound has several benefits to the individual and
reduces costs (18). Treating a diabetic foot wound improves function and quality
of life. Treatment allows the individual to return to ambulating, relieves health
care providers or caregivers from having to change dressings, and allows the
individual to participate in normal daily activit·es. Controlling infection maintains
the individual in good health and can ultimately prevent the occurrence of
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amputation. Treating the wound costs less and reduces cost by avoiding the
cost of amputation and hospita ization (18).
Hyperbaric Oxygen Therapy (HBO)
The use of hyperbaric oxygen (HBO) therapy is in it's beginn-ng in the
medical field_ It has been used for a little over forty years (37). The first clinical
use of the hyperbaric chamber was in 1955 by Churchi I-Davidson and was used
to resemble the effects of radiation therapy in cancer patients. Soon after, in
1956, Professor Ite Boerema at the University Hospital in Amsterdam performed
vascular and cardiac surgery under hyperbaric conditions in a chamber to
prolong the patient's tolerance to circulatory arrest (38). There is skepticism
among many medical professionals of what diseases or conditions it can treat.
The main concern many medical professionals have is that there has not been
sufficient scientific validation of the efficacy or safety of this treatment (37).
Currently, there are a limited number of conditions approved to be treated
by hyperbaric oxygen therapy. One condition is the enhancement of healing in
selected problem wounds, such as diabetic foot ulcers and venous ulcers. Other
disorders approved for treatment with hyperbaric oxygen therapy are:
decompression sickness, gas embolism, carbon monoxide and cyanide
poisoning, gas gangrene, osteomyelitis, sternal wound infections, radiation injury
to tissue, blOOd loss anemia, crush injury and other traumatic peripheral
ischemias, skin grafts and flaps, management of fungal disease, treatment of
thermal burns, and- pelvic radiation necrosis and radiation cyct·tis (38). All of the
conditions listed have a common pathophysiology of local or focal hypoxia and
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are the only approved conditions to be treated with HBO (2). HBO is used to
treat other conditions that are not approved, such as rheumatoid arthritis,
cirrhosis, and gastoduodenal ulcers. The effectiveness of HBO in the treatment
of these conditions remain unproven (37).
The use of HBO to treat diabetic foot ulcers is not recommended for all
individuals with this condition (2). Those with ulcers that are not severe (stage 1
or 2 on the Wagner scale) are first treated with more traditional forms of therapy.
Some of the traditional forms of therapy for foot ulcers include doing regular foot
exams, maintaining glycemic control, wearing special footwear, and keeping
weight/press'ure off the wound (1). Individuals that would be considered for HBO
include patients with class 3, 4, or 5 Wagner scale ulcers and those with
inadequate arterial flow in the extremities (2).
Hyperbaric oxygen therapy is administered in a mono- or multiplace
chamber for approximately 1-2 hours a day, 5-6 days a week. The average
number or treatments for optimal wound healing is 30-40 treatments (37). A
monoplace chamber is made to accommodate only one individual and is used
primarily for patients with chronic medical conditions. This chamber provides
a100% oxygen environment under increased pressure. A multiplace chamber
can hold several individuals at one time and is usua Iy used for patients with
acute medica1 problems and critically ill patients. In this chamber an attendant is
always present inside the chamber in case any complications arise. Th·s
chamber provides increased pressure, but the environment does not provide
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100% oxygen. Patients are requ·red to wear a mask, tight fitting hood or have an
endotracheal tube to provide the patient with 1000/0 oxygen (37).
The physiologic effects of hyperbaric oxygen therapy on the body assist in
the healing process of the diabetic foot ulcer. The oxygen evel and atmospheric
pressure while in the hyperbaric chamber playa part in causing physiological
changes in the body (39). In the normal environment, the composition of the air
is only 210/0 oxygen (38). HBO provides the patient with almost five times the
amount of oxygen than normal environment. While breathing in 100% oxygen
the patient is also under increased atmospheric pressure. The pressure
equivalent of 3 atmospheres (ATA), which is like being under 66 ft of sea water,
is used in the hyperbaric chamber (40). Increasing the pressure above this level
can be harmful by inducing the toxic effects of oxygen such as grand mal
seizures and damage to the lung tissue (38).
Under increased pressure and breathing 100% oxygen, the oxygen
content of the blood increases. Hemoglobin in normal conditions is 970/0
saturated with the oxygen breathed in. By changing the air to 100% oxygen, an
increase of 3% of hemoglobin-delivered oxygen will occur and the rest of the
oxygen will be dissolved in the plasma. By increasing the atmospheric pressure,
the oxygen dissolved in the plasma will increase by 2.3 vol%. Thus at 3 ATA,
more than 6 vol% of the plasma is saturated with oxygen (41). This increase of
oxygen content of the plasma is equal to ten to fifteen times more than the
normal saturation level of the plasma in a normal environment (2).
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The increased pressure also has an effect on the volume of the gas
bubbles in the blood. Boyle's law explains the reason for change in the volume
of gas bubbles in the blood while in the hyperbaric chamber. The basic theory of
Boyle's law is that at a constant temperature and mass, the volume of a perfect
gas varies inversely with pressure (19). Thus, as the pressure increases, the
size of the gas bubble decreases. At 3 ATA the bubble volume of a gas is
decreased by two thirds. This allows the intravascular bubbles that cause
obstruction to move to smaller vessels which then reduces damage to
extravascular tissue (37). As gas bubbles become microscopically small and
reach thousands of dynes per square centimeter, better circulation to areas with
poor circulation, such as the foot, is made possible (38). Increasing the
circulation in the foot and increasing the oxygen content of the blood allows for
greater re-oxygenation of ulcerated tissue to assist in wound healing (37).
Hyperbaric oxygen therapy increases the oxygen saturation of tissue.
Increased oxygen saturation of the tissue can assist in healing of a diabetic foot
ulcer. Fibroblasts synthesize collagen only when there is adequate oxygen in the
tissues. The deposition of collagen and it's ability to condense is highly
dependent of the amount of oxygen available to the tissue. With well-oxygenated
and hydrated tissues, epithelial cells can move and replicate to promote wound
healing (42).
Hyperbaric oxygen therapy is effective in healing diabetic foot ulcers and
preventing amputations. The results of a randomized study performed by Faglia
et al. (8) showed that hyperbaric oxygen therapy was successful in decreasing
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the number of amputations in subjects receiving HBO compared to those who did
not receive HBO (8). In this study, 35 subjects underwent hyperbaric oxygen
therapy for a diabetic foot ulcer and 33 subjects did not. Three subjects (8.6%) in
the treatment group underwent amputation and 11 subjects (33.30/0) in t e
nontreatment group underwent amputation. The difference ·n the amputation
rate between the groups was found to be statistically significant (p=O.016).
Baroni et al. (43) reported success in decreasing the rate of amputations
in patients receiving hyperbaric oxygen therapy for the diabetic foot ulcer. In this
study, 18 subjects were in the treatment group (received HBO therapy) and 10
were in the nontreatment group (did not receive HBD therapy). Two subjects in
the treatment group and nine subjects in the nontreatment group did not heal.
The rate of amputation in the treatment group was 12.5°k, whereas the
amputation rate in the nontreatment group was 40% which was statistically
significant at (p<O.001). Sixteen patients in treatment group healed and were
discharged in 62 days compared to nine patients in the nontreated group that did
not heal in 82 days.
Hyperbaric oxygen therapy is a useful treatment in reducing the risk of
amputations in subjects with diabetic ulcers. The results of these studies and the
physiologically effects of hyperbaric oxygen therapy on the body give good
supportive evidence that the use of hyperbaric oxygen therapy is a beneficial
form of adjunctive treatment for the healing of diabetic foot ulcers and a
preventive measure to amputation.
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Understanding the pathophysiology and care needed for diabetic foot
ulcers are useful in providing an individual with proper care for their condition.
This understanding can also provide healthcare providers with more direction in
using new treatments that may enhance those already in place. With further
understanding of wound healing and the use of effective treatments, the severity
of ulcers and risk of amputations can be reduced and provide individuals with
diabetes a better quality of life and health.
In summary, the maintenance of good glycemic control and the use of
hyperbaric oxygen therapy may be a good interdisciplinary approach in assisting
in the healing of diabetic foot ulcers. There are no present studies that
investigate the effect of the combination of good glycemic control and hyperbaric
oxygen therapy on the healing of diabetic foot ulcers. Information provided from
the literature review leads to the hypothesis of this study: Subjects with diabetes
receiving hyperbaric oxygen therapy for the treatment of diabetic foot ulcers with
successful wound healing will have better glucose concentrations compared to
those that had amputations.
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Table 1. Risk factors for lower extremity amputations of the diabetic foot
Peripheral neuropathy- loss of sensation in the foot
Peripheral vascular disease- poor circulation
High pressure points formed from foot deformity and callus formation
Autonomic neuropathy- decrease sweating and dry, fissured skin
Obesity
Impaired vision
Poor glycemic control- causes impaired wound hea ing
Poor foot wear- causes skin breakdown and increases pressure points
History of foot ulcers and lower extremity amputation




This study is a retrospective hospital based study that was approved by
the Integris Baptist Hospital Institutional Review Board and the Oklahoma State
University Institutional Review l;3oard (Appendix B &C). Data were collected
from a retrospective review of consecutive medical charts in the baromedica unit
at Integris Baptist Medical Center in Oklahoma City, Oklahoma. Fifty-eight charts
of patients admitted in 1997 to 2001 for hyperbaric oxygen therapy were
reviewed. Thirty-five of the charts reviewed were not included in the study due
because the patients did not meet the inclusion criteria because the chart did not
have adequate information.
Subjects
The subjects used in this study were patients with diabetes that had
received outpatient hyperbaric oxygen therapy for diabetic ulcers at Integris
Baptist Medical Center in Oklahoma City, Oklahoma from July 1997 to April
2001. All subjects received the hyperbaric oxygen therapy in the morning.
Twenty-three subjects were included in this study. To be included in this study,
subjects had to have the diagnosis of type 1 or type 2 diabetes with a diabetic
foot ulcer, had undergone outpatient HBD therapy for the treatment of the
28
diabetic foot ulcer and were compliant with HBc treatments. Be,ing comprant
with HBO therapy was defined as not m·ssing treatments and completing all
treatments that the physician ordered for the patient. Lastly, the subjects had to
be free of any other infections.
Data Collection
Medical charts from Integris Baptist Medical Center between July 1997
and April 2001 were reviewed starting from the most recent patients that received
HBD for the treatment of a diabetic foot ulcer. Sampling was consecutive.
Patient confidentiality was assured by not identifying the patient in any way on
the data collection sheet. The patient's name, social security number, medical
chart number, address, phone number, or any other identifying data was not
recorded. Instead, each patient's chart reviewed was given an identification
number between one and twenty-three. The patient age, sex, diagnoses,
glucose levels before HBc treatments, location of ulcer, color stages of ulcer
(initial and throughout treatment), dates of treatments, the number of treatments,
and amputations were collected. The diagnosis of type 1 or type 2 diabetes was
not included in the medical charts. Only the diagnosis of diabetes was in the
medical charts. These data were recorded onto a data collection sheet to be
analyzed for later analysis (Appendix D).
Whole blood glucose levels (random, not fasting) before HBD treatment
were used to determine the patient's glucose concentrations during the time of
the treatment. The nurse present took and recorded each subject's whole blood
glucose level with the glucometer in the unit. Average blood glucose levels
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throughout HBO treatment were estimated by using the Excel program. This
provided a good estimate of the average blood glucose level before each HBO
treatment. The range of blood glucose levels before HBc therapy were also
recorded to determine if blood glucose levels were stable.
In order to determine healing of the ulcer, the stage of the wound was
evaluated and recorded in the med·cal chart by a nurse. The colors red, yellow,
and black were used. Red indicated the wound was in the healing stage (21).
Yellow indicated the wound was not ready for healing due to infection or fibrinous
slough. Black indicated necrotic non-healing tissue. The number of treatments
per color stage was also recorded. This would indicate how long the healing
process took in each stage of color.
Individuals that required an amputation were recorded in the medical
chart. On the last HBO treatment given to the patient, the date for surgery to
amputate was recorded. This indicated which patients required an amputation.
Analysis of Data
The Excel program was used to compute means, standard deviations and
percents of the descriptive results of two groups. The subjects were grouped
according to whether the individual received an amputation. Means and
standard deviations for age, number of hyperbaric oxygen therapy treatments -n
each stage (black, yellow and red), total number of hyperbaric oxygen therapy
treatments and glucose concentrations throughout HBO and in each stage
(black, yellow and red) were computed for each group_ Percents were computed
for the ration of individuals with specific diagnoses. T-tests were computed to
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determine if there was a significant difference between the groups in glucose
concentrations throughout the treatments, in each stage (black, yellow and red),
and minimum and maximum glucose concentrations. The t-test was a so used to
determine if there was a significant difference in the number of HBO treatments
the groups received.
Due to the lack of objective data in the patient's medical charts, each
group is described in detail to give a clearer picture of the subjects in each group.





Twenty-three subjects with diabetic foot ulcers were included in this study
by a retrospective review of medical charts in the baromedical unit at Integris
Baptist Medical Center in Oklahoma City, Oklahoma. The study included 15
males and 8 females. All subjects were diagnosed with diabetes and underwent
hyperbaric oxygen therapy (HBO) for the treatment of a diabetic foot ulcer. Most
(73.90/0) of the subjects in this study were diagnosed with peripheral vascular
disease which is identified as a risk factor for the development of diabetic foot
ucers. Other diagnoses included heart disease (69.6%), hypertension (73.90/0),
cancer (8.7%), COPD (13.0%), kidney disease (13.0%), cellulitis (4.3%), and
anemia (4.30/0).
Of the thirteen subjects that did not require an amputation, 9 were male
and 4 were female. The average age of this group was 61.4.± 9.8 years and
they had an average of 20.4.:!:4.1 HBO treatments. The average glucose levels of
this group in th.e wound healing stages of red, yellow and black were 174.9 .:!:
55.0 mg/dL, 178.5.:!: 58.3 mg/dL, and 200.0 ± 115.8 mg/dL, respectively (Table 1
and Table 2).
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Two subjects in non-amputated group began HBD treatment in the red
stage of wound healing (Figure 1). One of the subjects that began in the red
stage remained red throughout his 20 treatments and the other subject that
began in the red stage declined to the yellow stage after three treatments. The
wound then advanced to the red stage again after ten treatments and was able to
heal after eight more treatments.
Nine subjects in the non-amputated group began HBO treatment in the
yellow stage of wound healing (Figure 1). Eight of the nine subjects that began
treatment in the yellow stage of wound healing advanced to the red stage and
were able to heal. One subject that began in the yellow stage of healing declined
to the black stage and received four treatments in this stage. This subject was
able to advance to the red stage of wound healing and was able to heal.
Two subjects in this group began HBO in the black stage. They were both
able to advance to the yellow stage and finally to the red stage of wound healing
(Figure 1).
Of the ten subjects in this study that required an amputation, 6 were male
and 4 were female. The average age of this group was 64.6 ±: 8.7 years and had
an average of 16.3±7.1 HBO treatments. The average glucose levels in the red,
yellow and black stages were 198.0 ±: 0.0 mg/dL, 169.9:!: 40.7mg/dL, and 183.2
.± 34.3 mg/dL, respectively (Table 1 and Table 2).
Only one subject in this group began HBO in the red stage of wound
healing (Figure 2). This subject regressed throughout the treatment. Ultimately,
the ulcer worsened to the extent the physician ordered an amputation.
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Three sUbjects in this group began HBO in the yellow stage of wound
healing (Figure 2). One subject worsened to black aind received one treatment
and then advanced back to the yellow stage. After six treatments in the yellow
stage the physician ordered an amputation. Two of the subjects that began HBO
in the yellow stage of wound healing degenerated to the black stage and did not
heal which ultimately resulted in amputations.
Six subjects in this group began HBO in the black stage of wound heal"ng
(Figure 2). Four subjects that began treatment in the black stage did not improve
and required an amputation. One subject that began treatment in the black stage
advanced to the yellow stage and received eight treatments in t e yellow stage.
The physician ordered an amputation after those treatments. Lastly, one subject
that began treatment in the black stage of healing advanced to the yellow stage
and received six treatments. This subject then declined to the black stage again
and received two more treatments before amputation.
T-tests were performed to determine if there were significant differences
between the groups (non-amputated and amputated). The significance level of
p=O.005 was used for all of the t-tests. Blood glucose concentrations from each
group in stages of black and yellow were compared. The results were as follows:
black p=O.652237 and yellow p= 0.734594. The t-test results showed there was
no significant difference in the glucose levels between the groups in each wound
healing stage. A t-test in the red stage of healing was unable to be computed
because only one subject in the amputated group was in the red stage. The t-
test for overall glucose levels between the groups was p=O.987601. This
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indicates that there was no significance in glucose concentrations throughout the
HBO treatments. Minimum and maximum glucose concentrations were
compared. The t-test results were p=O.815054 (minimum) and p=O.712534
(maximum). The t-test determined that there was no significance between the
group's minimum and maximum glucose concentrations.
T-test were also used to determine if there was a significant difference in
the age, number of HBO treatments each group received, the number of
diagnoses between the groups. The result of the t-te5t showed there was no
significant difference in age (p=O.414658), number of HBD treatments
(p=O.967981) or number of diagnoses (0.691848) between the amputated group
and the healed group.
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Table 1. Description of subjects in this study
Non-amputated Amputated
n=13 n=10





(no. ofsubjects with each diagnosis)
Diabetes mellitus 13 10
Heart disease 8 8
Hypertension 10 6
Peripheral vascular disease 9 7
Cancer 1 1
COPO 2 1








Table 2. Comparison of number of treatments and glucose levels by wound healing stages and whether patient was healed or
amputated.
Number of treatments ± SO Glucose level ± SD (mg/dL)
Minimum glucose level Maximum glucose level
Wound
±SD (mg/dL) ± SO (mg/dL)
Stage
Healed Amputated Healed Amputated Healed Amputated Healed Amputated
All 20.4±4.1 16.3±7.1 178.9±.61.3 178.8±35.7 126.8±59.2 123.1±.37.5 240.2±78.4 232.0:!:61.0
Black 1.0±2.2 8.9±9.6 200.0±115.8 183.2±34.3 146.0.±99.2 132.8±32.3 254.3±128 249.1±69.6
Yellow 9.6±4.8 5.5±5.2 178.5.±58.3 169.4±40.7 112.2±45.0 101.7±40.1 254.0±71.3 215.1±.40.7



























Figure 1. Systematic representation of wound healing, classified by the red-


























Figure 2. Systematic representation of non-healing wounds, classified by the





This study was designed to determine if glucose concentrations have an
effect on wound healing in subjects with diabetic foot ulcers receiving hyperbaric
oxygen therapy. A retrospective review of medical charts in the baromedical unit
at Integris Baptist Medical Center in Oklahoma City, Oklahoma was conducted.
Data collected from the medical charts included age, sex, diagnoses, glucose
values, location of ulcer, wound coior stages, and if amputation occurred.
The results of the study indicated that there was no significant difference
in glucose concentrations between individuals that did not receive an amputation
and those that did receive an amputation. Both groups in this study had average
glucose concentrations above normal range and were very similar (178.9 and
178.8 mg/dL). The blood glucose levels were taken before each hyperbaric
oxygen therapy session. There are some possible reasons for elevated glucose
concentrations in the subjects. The blood glucose concentrations taken may
have :notbeen fasting and hyperbaric oxygen therapy treatments were taken in
the morning. Most of the subjects pro.bab y ·ust ate breakfast before coming to
the unit for treatments. This may cause elevated levels in the subjects. Another
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possible cause for elevated glucose concentrations is the presence of j,nfectionin
the ulcer. Infection and sickness elevates glucose concentrations in individ:ua,ls~
Lastly, most of the individuals probably have not had good glycemic control i'n the
past or present because the deve:lopment of ulcers occur with poor glycemic
control (6,9).
A study that supported relation between :gycemic control and
complications was the DCCT (6). The researchers studied 1441 patients with
type 1 diabetes and randomy assigned them to a group. One group took part in
intensive therapy to keep tight glycemic control by the use of insulin best fitting
for the subject. The control group received conventional treatment. Each subject
was monitored for 6.5 years and was assessed for the appearance or
progression of complications that arise from diabetes. The researchers in this
study observed that there was a reduction in clinical neuropathy (600/0) and a
reduction of peripheral vascular disease (40%) in subjects that maintained tight
glycemic control compared to those in the conventional treatment group. The
reduction of these complications (precursors for amputation) is a preventive
measure for the incidence of amputation.
In this study, both groups had similar glucose concentrations which were
above 140mg/dL. Thirteen subjects did not receive an amputation and ten
subjects did. Similar glucose conce·ntrations were observed in the groups (non-
amputees a:nd amputees)wh'ich contrary to the titerture (6,9) indicated that
glucose concentrations did not have an effect on the incidence of ampu ation.
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ri examining subject in thi's studyma:ny observatio,ns were made. One
was that only fewer subjects· (2 out of 13) in the non-amputated grou:p who began
HBO therapy in the black stage compared to subjects fn th,e amputated group (6
out of 10) that started in the black stage. This 'leads us to surmise that the
subjects that started HBO therapy at this stage were more likely to receive an
amputation compared to those that started in the red or-yeUow stage of wound
healing. Another observation was that most of the subjects were male (fifteen
male and 8 female). This agrees with information in the literature review that
indicated that those at high risk for the development of diabeti,c foot ulcers were
male between the ages of 45~ 64 (16). The development of d·abetic foot ulcers
increases with the duration of diabetes (24). The subjects in this study were in
their early sixties and may have had diabetes for a long duration.
Many other complications are related to incidence and prevalence of
ulcers and amputations(6, 9). A study by Moss et al. observed that good
glycemic control reduces the prevalence and incidence of lower extremity
amputations (9). This study included 1,210 subjects with diabetes diagnosed
before the age of thirty and 1,780 subjects with diabetes diagnosed after the age
of thirty. Baseline and follow-up examinati·ons were conducted. This risk of
amputation· in the younger onset subjects was 9.50/0 and was 10.50/0 in the older
onset subjects. Many indicators for amputation were observed in both groups.
Elevated glycos.ylated hemoglo:bin concentrations was a statistically ,significant
independent risk factor for the development of sores, ulcers and amputation.
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Other risk factors ·d,iscussedwere long duration of diabetes, smoking, proteinuria,
and low diastolic blood pressure.
This study has provided good insight to a possible future study to
investigate the importance of good glycemic concentrations on wound healing of
diabetic foot ulcers i:n subjects receivjnghyperbaric oxygen therapy. As
experience with this study, a retrospective review of medica,1 chart has shown
that a retrospective review of medical c,harts may not be a ra iable source of
information for the collection of data due to inconsistencies and/or the absence of
information available from medical charts such as history, physicals and charting
progress notes. Due to the small sample size and lack of in-depth information
about the subjects, this study was limited in scope. Obtaining information from a
retrospective review of medical charts presented frustrating obstacles. Exact
diagnosis of type 1 or type 2 diabetes was not recorded in the medical charts.
Medications or the use insulin to control diabetes were not recorded in the
medical chart.
Of the 58 medical charts of patients receiving HBO for the treatment of
diabetic foot ulcers, only 23 provided adequate data to be used for this study.
Many charts did not have history and physical reports (76.80/0), labs (92.9%) with
the exception of glucose levels, completed assessments, or adequate 'progress
notes (32.20/0). Information from these components would have provided
important information in understanding and analyzing the current health status of
the patient. These pro,blems could be addressed by doing a prospective study.
Suggestions for a Future Study
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A prospective study is a better research method to determine if glycemic
control has an effect on the :healing ofdi'a.betic foot ulcer in subjects rece·ving
HBO. It would provide a future investigator with measurable informat·on to form
conclusions.
A prospective study includes working closely with the other healthcare
providers in a facirty, providing intensive medical nutrition therapy with the
patients, obtaining labs to identify the nutritional status of the individual, and
keeping complete, in-depth medical charts. These interventions can provide a
future investigator with needed data to provide a more conclusive study.
A future prospective study on the effect of glycemic control on wound
healing in subjects receiving HBO can be more extens.ive and controUa'ble.
Direct communication with the subject can provide information that is not
available from medical charts such as eating habits, physical activity, and
feelings towards the condition. These factors can give the investigator better
insight of the subject and how well they understand the importance of controll:ing
diabetes to assist in wound healing and prevention of future compl.ications.
Understanding the subject allows for good medical nutrition therapy and
education. Providing education along with other healthcare providers on the
importance of maintaining good glycemic control and taking speci.al care of the
wound is beneficial for the patient.
A prospe'ctive study al·lows for blood to be drawn to assess the nutritional
status of the subject. Good nutritional status is essentia~1 for proper wound
healing. Labs such as albumin, sodium, potassium, calcium, hemoglobin and
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hematocrit are good indicators to use to assess the current nutritional status of
the subject. It can be planned for :in advance.
Assessing the glycemic control of the subject can be more relia:bleusing
hemoglobin A 1c in addition to glucose concentrations. Hemoglobin A1c would
provide the investigator with a good tool to measure the subjects true glyce,mic
control over the past 6-12 weeks. Glucose concentrations give the investigator
levels at only one time rather over an extended ti'me. Hemoglobin A 1c would be
a more accurate measure of glycemic control.
Thorough and consistent charting and assessments (initial and throughout
treatment) provides good information on the progress of the su,bject receiving
therapy for a wqund. Providing good information on the progress of wound
healing includes documentation on the measurement of the wound, color of the
wound, and any other changes in the subject's condition. This information
should be written in progress notes and/or an assessment form.
Assessing the healing of the diabetic foot ulcer can be more relia,ble using
measurements instead of colors. In this retrospective study, healing of foot
ulcers were determined by the color of the ulcer. Very few measurements were
taken throughout the treatment process. Measurements at each treatment were
not available to assess the healing rate of the ulcer but the color of the wound
was available. In a prospe·ctive study, good documentation of the measure·ments
of the wounds can provide a good tool in assessing thehea ing rate of diabetic
foot ulcers. To estimate the healing rate of the ,ulcers, th,e measureme,nt (area) of
the ulcer after the last h,yperbaric oxygen therapy treatment subtracted from the
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measurement (area) of the ulcer before the first hyperbaric oxygen therapy
treatment can, be quantified and divided by the umber of treatments. T,his will
provide more definitive data on the healing rate of the wound to compare to
glycemic control.
Overall, a future prospective study should include: working with a
multidisciplinary staff, communication and medical nutrition therapy on the
importance of glycemic control with the patient, labs to assess nutritional status,
thorough assessment! charting and measuring the wound each treatment.
These elements can provide a good future study.
Many opportunities are available when do·ng a prospective study. Most
importantly, communication with the patient allows for better understand·ng of the
individual. This can open a door of opportunity to further educate the patient on
the importance on controlling diabetes and taking good care of their health.
Prospective studies can provide the opportunity for collecting important
information that is otherwise not available when doing a retrospective study such
as wound measurements and lab values.
Conclusions
This study was not able to clearly show the relationship of glucose
concentrations and wound healing due to the small sample size and imited
information regarding the subjects but provides a good beginning for a future
study. This study has shown that obtaining viable data for this study requires a
prospective study. Relying on medical charts of the past does not guarantee that
all information that should be in the chart will be there. By doing a prospective
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study, with the assistance of other medicalhealthcare profess·onals, will ensure
that all data required to form a valid conclusion will be available.
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